Brand
GlaxoSmithKline LLC
2 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for GlaxoSmithKline LLC and translate it into plain English — free weekly digest, optional same-day alerts.
- 2024-06-12FDA-DrugClass IIITivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL dosing cup and one 10-mL oral dosing syringe, Rx Only, Mfd for: ViiV Healthcare Durham, NC, 27701, By: GlaxoSmithKline Durham, NC 27701, NDC 49702-255-37
Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
- 2024-01-03FDA-DrugClass IIIANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters total), Rx Only, Manufactured by GlaxoSmithKline Durham, NC 27701. NDC 0173-0869-10
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
Get notified about new GlaxoSmithKline LLC recalls
Free weekly digest. We email when a new federal recall affects GlaxoSmithKline LLC or anything else in your household.
Get the Sunday Brief